Thomas Powles
MD, MBBS
Professor of Genitourinary Oncology
👥Biography 个人简介
Thomas Powles is a global leader in urothelial cancer research who has led pivotal immunotherapy trials transforming the treatment of bladder and urothelial cancers. He led the IMvigor210 study establishing atezolizumab in cisplatin-ineligible urothelial cancer and contributed to multiple pembrolizumab bladder cancer trials. His research has advanced understanding of PD-L1 as a biomarker and identified patient populations most likely to benefit from checkpoint inhibition. He continues to lead international bladder cancer clinical trials and genomic studies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Thomas Powles 的研究动态
Follow Thomas Powles's research updates
留下邮箱，当我们发布与 Thomas Powles（Barts Cancer Institute, Queen Mary University of London）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment